NCT05325229 2022-10-13A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2 Unknown94 enrolled